Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masahiro Doi

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
The Review of Scientific Instruments|October 2, 2007
Continuous measurements of bronchial exposure induced by radon decay products during inhalationKazuki Iwaoka, Shinji Tokonami, Hidenori Yonehara, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|January 19, 2012
Characteristics of induced ventricular fibrillation cycle length in symptomatic Brugada syndrome patientsAtsushi Hiratsuka, Akihiko Shimizu, Takeshi Ueyama, et al.
Journal of Cell Science|March 20, 2009
Three-dimensional electron microscopy reveals new details of membrane systems for Ca2+ signaling in the heartTakeharu Hayashi, Maryann E Martone, Zeyun Yu, et al.
Cardiology|December 4, 2013
A low-dose β1-blocker effectively and safely slows the heart rate in patients with acute decompensated heart failure and rapid atrial fibrillationShigeki Kobayashi, Wakako Murakami, Takeki Myoren, et al.
Circulation|February 6, 2004
Valsartan restores sarcoplasmic reticulum function with no appreciable effect on resting cardiac function in pacing-induced heart failureShinichi Okuda, Masafumi Yano, Masahiro Doi, et al.
American Journal of Physiology. Heart and Circulatory Physiology|November 16, 2002
A new cardioprotective agent, JTV519, improves defective channel gating of ryanodine receptor in heart failureMasateru Kohno, Masafumi Yano, Shigeki Kobayashi, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|May 9, 2003
Effects of flecainide on the electrophysiological properties of atrial vulnerability in humansYasuhiro Yoshiga, Akihiko Shimizu, Toshihiko Yamagata, et al.
Circulation|June 22, 2005
Defective regulation of interdomain interactions within the ryanodine receptor plays a key role in the pathogenesis of heart failureTetsuro Oda, Masafumi Yano, Takeshi Yamamoto, et al.
Circulation|March 20, 2002
Propranolol prevents the development of heart failure by restoring FKBP12.6-mediated stabilization of ryanodine receptorMasahiro Doi, Masafumi Yano, Shigeki Kobayashi, et al.
Circulation|January 29, 2003
FKBP12.6-mediated stabilization of calcium-release channel (ryanodine receptor) as a novel therapeutic strategy against heart failureMasafumi Yano, Shigeki Kobayashi, Masateru Kohno, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
The Review of Scientific Instruments|October 2, 2007
Continuous measurements of bronchial exposure induced by radon decay products during inhalationKazuki Iwaoka, Shinji Tokonami, Hidenori Yonehara, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|January 19, 2012
Characteristics of induced ventricular fibrillation cycle length in symptomatic Brugada syndrome patientsAtsushi Hiratsuka, Akihiko Shimizu, Takeshi Ueyama, et al.
Journal of Cell Science|March 20, 2009
Three-dimensional electron microscopy reveals new details of membrane systems for Ca2+ signaling in the heartTakeharu Hayashi, Maryann E Martone, Zeyun Yu, et al.
Cardiology|December 4, 2013
A low-dose β1-blocker effectively and safely slows the heart rate in patients with acute decompensated heart failure and rapid atrial fibrillationShigeki Kobayashi, Wakako Murakami, Takeki Myoren, et al.
Circulation|February 6, 2004
Valsartan restores sarcoplasmic reticulum function with no appreciable effect on resting cardiac function in pacing-induced heart failureShinichi Okuda, Masafumi Yano, Masahiro Doi, et al.
American Journal of Physiology. Heart and Circulatory Physiology|November 16, 2002
A new cardioprotective agent, JTV519, improves defective channel gating of ryanodine receptor in heart failureMasateru Kohno, Masafumi Yano, Shigeki Kobayashi, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|May 9, 2003
Effects of flecainide on the electrophysiological properties of atrial vulnerability in humansYasuhiro Yoshiga, Akihiko Shimizu, Toshihiko Yamagata, et al.
Circulation|June 22, 2005
Defective regulation of interdomain interactions within the ryanodine receptor plays a key role in the pathogenesis of heart failureTetsuro Oda, Masafumi Yano, Takeshi Yamamoto, et al.
Circulation|March 20, 2002
Propranolol prevents the development of heart failure by restoring FKBP12.6-mediated stabilization of ryanodine receptorMasahiro Doi, Masafumi Yano, Shigeki Kobayashi, et al.
Circulation|January 29, 2003
FKBP12.6-mediated stabilization of calcium-release channel (ryanodine receptor) as a novel therapeutic strategy against heart failureMasafumi Yano, Shigeki Kobayashi, Masateru Kohno, et al.
Pageof 4